$ORGS
Orgenesis Inc. Stock $orgs

$orgs Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224030760 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue		$246.0K
YoY Change		-96.47%
Cost Of Revenue		$538.0K
YoY Change		-83.35%
Gross Profit		-$292.0K
YoY Change		-107.8%
Gross Profit Margin		-118.7%
Selling, General & Admin		$2.061M
YoY Change		-38.24%
% of Gross Profit
Research & Development		$1.489M
YoY Change		-57.78%
% of Gross Profit
Depreciation & Amortization		$706.0K
YoY Change		18.26%
% of Gross Profit
Operating Expenses		$3.550M
YoY Change		-48.28%
Operating Profit		-$4.250M
YoY Change		27.67%
Interest Expense		-$835.0K
YoY Change		28.46%
% of Operating Profit
Other Income/Expense, Net		-$815.0K
YoY Change		24.43%
Pretax Income		-$9.361M
YoY Change		162.21%
Income Tax		$5.000K
% Of Pretax Income
Net Earnings		-$8.904M
YoY Change		115.75%
Net Earnings / Revenue		-3619.51%
Basic Earnings Per Share		$0.23
Diluted Earnings Per Share		$0.23
COMMON SHARES
Basic Shares Outstanding	46.93M shares	34.34M shares
Diluted Shares Outstanding		38.86M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$77.00K
YoY Change		-57.22%
Cash & Equivalents		$77.00K
Short-Term Investments
Other Short-Term Assets		$2.031M
YoY Change		-62.02%
Inventory
Prepaid Expenses
Receivables		$240.0K
Other Receivables		$0.00
Total Short-Term Assets		$2.348M
YoY Change		-74.74%
LONG-TERM ASSETS
Property, Plant & Equipment		$15.90M
YoY Change		1173.1%
Goodwill		$1.211M
YoY Change		-67.3%
Intangibles		$8.724M
YoY Change		13.58%
Long-Term Investments		$8.000K
YoY Change		-99.97%
Other Assets		$331.0K
YoY Change		-53.84%
Total Long-Term Assets		$28.23M
YoY Change		-37.92%
TOTAL ASSETS
Total Short-Term Assets		$2.348M
Total Long-Term Assets		$28.23M
Total Assets		$30.58M
YoY Change		-44.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$13.41M
YoY Change		238.8%
Accrued Expenses		$2.789M
YoY Change		24.79%
Deferred Revenue		$350.0K
YoY Change
Short-Term Debt		$1.186M
YoY Change
Long-Term Debt Due		$1.993M
YoY Change		-15.62%
Total Short-Term Liabilities		$31.70M
YoY Change		149.39%
LONG-TERM LIABILITIES
Long-Term Debt		$8.059M
YoY Change		-54.84%
Other Long-Term Liabilities		$371.0K
YoY Change		518.33%
Total Long-Term Liabilities		$14.67M
YoY Change		-18.92%
TOTAL LIABILITIES
Total Short-Term Liabilities		$31.70M
Total Long-Term Liabilities		$14.67M
Total Liabilities		$46.37M
YoY Change		50.54%
SHAREHOLDERS EQUITY
Retained Earnings		-$195.3M
YoY Change		50.22%
Common Stock		$5.000K
YoY Change		-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$1.266M
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity		-$15.50M
YoY Change
Total Liabilities & Shareholders Equity		$30.58M
YoY Change		-44.17%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income		-$8.904M
YoY Change		115.75%
Depreciation, Depletion And Amortization		$706.0K
YoY Change		18.26%
Cash From Operating Activities		-$5.907M
YoY Change		-0.12%
INVESTING ACTIVITIES
Capital Expenditures		$1.000K
YoY Change		-99.8%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities		-$1.000K
YoY Change		-99.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		6.511M
YoY Change		33.26%
NET CHANGE
Cash From Operating Activities		-5.907M
Cash From Investing Activities		-1.000K
Cash From Financing Activities		6.511M
Net Change In Cash		603.0K
YoY Change		-123.9%
FREE CASH FLOW
Cash From Operating Activities		-$5.907M
Capital Expenditures		$1.000K
Free Cash Flow		-$5.908M
YoY Change		-8.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38416
	dei	Entity Registrant Name EntityRegistrantName	ORGENESIS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0583166
	dei	Entity Address Address Line1 EntityAddressAddressLine1	20271 Goldenrod Lane
	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876
	dei	City Area Code CityAreaCode	(480)
	dei	Local Phone Number LocalPhoneNumber	659-6404
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	ORGS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	642000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	88000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2017000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	34000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4076000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	38000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1475000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7375000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	351000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1211000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	10476000	usd
CY2023Q4	us-gaap	Assets Assets	14552000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47212473	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46925906	shares
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	65000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-176622000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-20983000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-20983000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14552000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	387000	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	538000	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001460602
CY2024Q2	us-gaap	Inventory Net InventoryNet		usd
CY2023Q4	ORGS	Advance Payments From Customer AdvancePaymentsFromCustomer		usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2023Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent		usd
CY2023Q4	ORGS	Contingent Consideration Non Current ContingentConsiderationNonCurrent		usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q2	ORGS	Change In Contingent Consideration ChangeInContingentConsideration		usd
	ORGS	Change In Contingent Consideration ChangeInContingentConsideration		usd
CY2024Q2	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet		usd
CY2024Q2	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable		usd
CY2023Q2	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable		usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable		usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q2	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses		usd
	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses		usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2024Q2	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera		usd
	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera		usd
	ORGS	Stock Issued During Period Value Issuance Of Shares Due To Exercise Of Warrants StockIssuedDuringPeriodValueIssuanceOfSharesDueToExerciseOfWarrants		usd
CY2024Q2	ORGS	Stock Issued During Period Value Issuance Of Shares And Receipts On Account Of Shares And Warrants StockIssuedDuringPeriodValueIssuanceOfSharesAndReceiptsOnAccountOfSharesAndWarrants		usd
	ORGS	Convertible Loan Induced Conversion Expenses ConvertibleLoanInducedConversionExpenses		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable		usd
	ORGS	Credit Loss Related To Obi CreditLossRelatedToObi		usd
	ORGS	Change In Contingent Consideration ChangeInContingentConsideration		usd
	ORGS	Increase Decrease In Related Parties Net IncreaseDecreaseInRelatedPartiesNet		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	ORGS	Impact To Cash Resulting From Deconsolidation ImpactToCashResultingFromDeconsolidation		usd
	ORGS	Impact To Cash Resulting From Another Deconsolidation ImpactToCashResultingFromAnotherDeconsolidation		usd
	ORGS	Proceeds From Transaction With Redeemable Noncontrolling Interest That Do Not Acquire Control Of Subsidiary ProceedsFromTransactionWithRedeemableNoncontrollingInterestThatDoNotAcquireControlOfSubsidiary		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts		usd
	ORGS	Receipt From Germ Free ReceiptFromGermFree		usd
	ORGS	Exchange Of Convertible Loans For Equity ExchangeOfConvertibleLoansForEquity		usd
	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment		usd
	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring		usd
CY2024Q2	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue		usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue		usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue		usd
	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable		usd
	ORGS	Contract With Customer Liability Realizations ContractWithCustomerLiabilityRealizations		usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46925906	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	837000	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	1079000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29234000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	240000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	952000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	2348000	usd
CY2024Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	249000	usd
CY2024Q2	ORGS	Investments To Associates InvestmentsToAssociates	8000	usd
CY2023Q4	ORGS	Investments To Associates InvestmentsToAssociates	8000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15901000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8724000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1805000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	1211000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	331000	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	28229000	usd
CY2024Q2	us-gaap	Assets Assets	30577000	usd
CY2024Q2	ORGS	Advance Payments From Customer AdvancePaymentsFromCustomer	6720000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2789000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2218000	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	767000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	740000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1634000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1079000	usd
CY2024Q2	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	2733000	usd
CY2023Q4	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	2180000	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1186000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	650000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	62000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	18000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	465000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	216000	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1931000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2670000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	31700000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16407000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1318000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	96000	usd
CY2024Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	2762000	usd
CY2024Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	5296000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	18967000	usd
CY2024Q2	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	96000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4000	usd
CY2024Q2	ORGS	Contingent Consideration Non Current ContingentConsiderationNonCurrent	4825000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	371000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14669000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	19128000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	46369000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	35535000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32163630	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31877063	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	180752000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	156837000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	302000	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	286567	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	286567	shares
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-195291000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-15498000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	-294000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15792000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30577000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	246000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	255000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	3232000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1030000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5954000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	-292000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-3119000	usd
	us-gaap	Gross Profit GrossProfit	-643000	usd
	us-gaap	Gross Profit GrossProfit	-5699000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1489000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3527000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3859000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6808000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	226000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	208000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	379000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	415000	usd
CY2024Q2	ORGS	Change In Contingent Consideration ChangeInContingentConsideration	182000	usd
	ORGS	Change In Contingent Consideration ChangeInContingentConsideration	182000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2725000	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-500000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24367000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	14878000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2061000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18216000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8117000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31744000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4250000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-25070000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13180000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-44666000	usd
CY2023Q2	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-5343000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-66000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-5343000	usd
CY2024Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	8000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	8000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2000	usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable	2688000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-141000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-815000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-692000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1667000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1373000	usd
CY2024Q2	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses	-4304000	usd
	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses	-4304000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9361000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31102000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19350000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54350000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	91000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	220000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-9366000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-31193000	usd
	us-gaap	Profit Loss ProfitLoss	-19371000	usd
	us-gaap	Profit Loss ProfitLoss	-54570000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-462000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5650000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-702000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9557000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-8904000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-25543000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18669000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-45013000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.63
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38860727	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38860727	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28603597	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28603597	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35979567	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35979567	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27546229	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27546229	shares
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-9366000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-31193000	usd
	us-gaap	Profit Loss ProfitLoss	-19371000	usd
	us-gaap	Profit Loss ProfitLoss	-54570000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-176000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	11000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-237000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	52000	usd
CY2023Q2	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera	-384000	usd
	ORGS	Release Of Translation Adjustment Due To Deconsolidation Of Octomera ReleaseOfTranslationAdjustmentDueToDeconsolidationOfOctomera	-384000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	9190000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	30820000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	19134000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	54238000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	462000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	5650000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	702000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	9557000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8728000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25170000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18432000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44681000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-20983000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	215000	usd
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	82996	shares
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	690000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	20311000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	31000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2496000	usd
	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	408000	usd
	ORGS	Stock Issued During Period Value Issuance Of Shares Due To Exercise Of Warrants StockIssuedDuringPeriodValueIssuanceOfSharesDueToExerciseOfWarrants	20000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	141000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19134000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15792000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29071000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	311000	usd
	ORGS	Stock Issued During Period Value Issuance Of Shares And Warrants Net Of Issuance Costs StockIssuedDuringPeriodValueIssuanceOfSharesAndWarrantsNetOfIssuanceCosts	3341000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	449000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	287000	usd
	ORGS	Adjustments To Additional Paid In Capital Deconsolidation AdjustmentsToAdditionalPaidInCapitalDeconsolidation	8430000	usd
	ORGS	Adjustments To Additional Paid In Capital Redemption Value Of Redeemable Noncontrolling Interest AdjustmentsToAdditionalPaidInCapitalRedemptionValueOfRedeemableNoncontrollingInterest	-9406000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45215000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12732000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27549000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	129000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	464000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	20311000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	30000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9190000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15792000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9989000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	152000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	100000	usd
CY2023Q2	ORGS	Adjustments To Additional Paid In Capital Deconsolidation AdjustmentsToAdditionalPaidInCapitalDeconsolidation	8430000	usd
CY2023Q2	ORGS	Adjustments To Additional Paid In Capital Redemption Value Of Redeemable Noncontrolling Interest AdjustmentsToAdditionalPaidInCapitalRedemptionValueOfRedeemableNoncontrollingInterest	-5735000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-25468000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12732000	usd
	us-gaap	Profit Loss ProfitLoss	-19371000	usd
	us-gaap	Profit Loss ProfitLoss	-54570000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	936000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	311000	usd
	ORGS	Convertible Loan Induced Conversion Expenses ConvertibleLoanInducedConversionExpenses	4304000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-66000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-5343000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1087000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1175000	usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable	2688000	usd
	ORGS	Credit Loss Related To Obi CreditLossRelatedToObi	2049000	usd
	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	-48000	usd
	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	214000	usd
	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	-24000	usd
	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	67000	usd
	ORGS	Change In Contingent Consideration ChangeInContingentConsideration	182000	usd
	ORGS	Interest Expense Accrued On Loans And Convertible Loans InterestExpenseAccruedOnLoansAndConvertibleLoans	-1192000	usd
	ORGS	Interest Expense Accrued On Loans And Convertible Loans InterestExpenseAccruedOnLoansAndConvertibleLoans	-300000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-141000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	70000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-30144000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1592000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1857000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	389000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4000	usd
	ORGS	Increase Decrease In Related Parties Net IncreaseDecreaseInRelatedPartiesNet	1000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2466000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2891000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	12000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	245000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-8000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	123000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-9000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10348000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13154000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	205000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1796000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	139000	usd
	ORGS	Impact To Cash Resulting From Deconsolidation ImpactToCashResultingFromDeconsolidation	5000	usd
	ORGS	Impact To Cash Resulting From Another Deconsolidation ImpactToCashResultingFromAnotherDeconsolidation	973000	usd
	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	-2000	usd
	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	33000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-69000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2802000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2528000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3341000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	75000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5485000	usd
	ORGS	Proceeds From Transaction With Redeemable Noncontrolling Interest That Do Not Acquire Control Of Subsidiary ProceedsFromTransactionWithRedeemableNoncontrollingInterestThatDoNotAcquireControlOfSubsidiary	5000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3000000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	145000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	30000	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	947000	usd
	ORGS	Receipt From Germ Free ReceiptFromGermFree	6720000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10125000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10796000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-292000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5160000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-31000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1479000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6369000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1156000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1227000	usd
	ORGS	Exchange Of Convertible Loans For Equity ExchangeOfConvertibleLoansForEquity	16007000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	191000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	753000	usd
	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment	14000	usd
	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring	287000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
	us-gaap	Interest Paid Net InterestPaidNet	785000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-195291000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10348000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zqoQT7nomWee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zBpsQF1OX181">Use of Estimates in the Preparation of Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, judgments and methodologies. The Company bases its estimates on historical experience and on various other assumptions that it believes are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity, the amount of revenues and expenses, determination of loss on deconsolidation, valuation of investments, purchase price allocations, goodwill impairment, and assessment of credit losses and purchase price allocation including contingent consideration. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	387000	usd
	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	666000	usd
	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	-279000	usd
	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	3585000	usd
	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-8229000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-66000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	8000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1087000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-141000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1667000	usd
	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses	-4304000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19350000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	255000	usd
	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	5482000	usd
	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	-5227000	usd
	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	6552000	usd
	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-31712000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-5343000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1175000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
	ORGS	Credit Loss On Convertible Loan Receivable CreditLossOnConvertibleLoanReceivable	2688000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1373000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54350000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	246000	usd
CY2024Q2	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	289000	usd
CY2024Q2	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	-43000	usd
CY2024Q2	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	1318000	usd
CY2024Q2	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-2183000	usd
CY2024Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	8000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	706000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-815000	usd
CY2024Q2	ORGS	Convertible Loans Induced Conversion Expenses ConvertibleLoansInducedConversionExpenses	-4304000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9361000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113000	usd
CY2023Q2	ORGS	Cost Of Revenue Excluding Depreciation And Amortization Expenses CostOfRevenueExcludingDepreciationAndAmortizationExpenses	2996000	usd
CY2023Q2	ORGS	Gross Profit Excluding Depreciation And Amortization Expenses GrossProfitExcludingDepreciationAndAmortizationExpenses	-2883000	usd
CY2023Q2	ORGS	Research And Development Expense Excluding Depreciation And Amortization Expenses ResearchAndDevelopmentExpenseExcludingDepreciationAndAmortizationExpenses	3395000	usd
CY2023Q2	ORGS	Operating Expenses Excluding Depreciation And Amortization Expenses OperatingExpensesExcludingDepreciationAndAmortizationExpenses	-18195000	usd
CY2023Q2	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-5343000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	597000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-692000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31102000	usd
	ORGS	Recognized Loss On Deconsolidation RecognizedLossOnDeconsolidation	66000	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1186000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	650000	usd
CY2024Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.85
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	50000000	shares
	ORGS	Share Based Compensation Arrangement By Restricted Stock Units Vesting Rights ShareBasedCompensationArrangementByRestrictedStockUnitsVestingRights	Immediate
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	26000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Consideration for a past debt
CY2024Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	164000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	500000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	500000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.03
CY2024Q1	ORGS	Description Of Warrant Vesting DescriptionOfWarrantVesting	One third on March 7, 2024, one third on June 5, 2024, and one third on September 3, 2024.
CY2024Q1	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-03-06
CY2024Q2	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	500000	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.03
CY2024Q2	ORGS	Description Of Warrant Vesting DescriptionOfWarrantVesting	One third on April 18, 2024, one third on July 18, 2024, and one third on October 18, 2024.
CY2024Q2	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-04-17
CY2024Q2	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	500000	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.03
CY2024Q2	ORGS	Description Of Warrant Vesting DescriptionOfWarrantVesting	One third on April 16, 2024, one third on July 16, 2024, and one third on October 16, 2024.
CY2024Q2	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-04-22
CY2024Q2	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Strategic advisor agreement
CY2024Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	475000	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.03
CY2024Q2	ORGS	Description Of Warrant Vesting DescriptionOfWarrantVesting	One third on May 21, 2024, one third on August 21, 2024, and one third on November 21, 2024.
CY2024Q2	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-05-21
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	664000	shares
CY2022	ORGS	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	326000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-8904000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-25543000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18669000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-45013000	usd
CY2023Q2	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	3671000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8904000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21872000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18669000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45013000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38860727	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38860727	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28603597	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28603597	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35979567	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35979567	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27546229	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27546229	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.63
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	246000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	387000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	255000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	88000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36183000	usd
	ORGS	Accounts Receivable Reconsolidation AccountsReceivableReconsolidation	82000	usd
	ORGS	Accounts Receivable Reconsolidation AccountsReceivableReconsolidation	-5985000	usd
	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	380000	usd
	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	293000	usd
	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-822000	usd
	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-6045000	usd
	ORGS	Accounts Receivable Allowances For Doubtful Accounts AccountsReceivableAllowancesForDoubtfulAccounts	512000	usd
	ORGS	Accounts Receivable Allowances For Doubtful Accounts AccountsReceivableAllowancesForDoubtfulAccounts	-24388000	usd
	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable	-52000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	240000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	110000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	36000	usd
	ORGS	Contract With Customer Liability Realizations ContractWithCustomerLiabilityRealizations	10000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	350000	usd
CY2024Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	8340	usd
CY2024Q2	ORGS	Advance Payment From Customer AdvancePaymentFromCustomer	6720	usd
	us-gaap	Loss Contingency Actions Taken By Plaintiff LossContingencyActionsTakenByPlaintiff	In the Complaint, the plaintiffs are seeking that the Court issue a declaratory remedy whereby the defendants are required to pay royalties to the plaintiffs at the rate of 7% of the sales and 24% of any and all revenues in consideration for sublicenses related to any product, service or process that contain know-how and technology of Sheba and any and all know-how and technology either developed or supervised by Prof. Ferber in the field of cell therapy, including in the category of the point-of-care platform and any and all services and products in relation to the defendants’ CDMO activity
CY2022Q1	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	10000000
CY2023Q3	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	896000	usd
CY2023Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	40140
CY2023Q4	us-gaap	Shares Issued SharesIssued	11869600	shares

Files In Submission

Name	View Source	Status
0001493152-24-030760-index-headers.html	Edgar Link	pending
0001493152-24-030760-index.html	Edgar Link	pending
0001493152-24-030760.txt	Edgar Link	pending
0001493152-24-030760-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgs-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
orgs-20240630_cal.xml	Edgar Link	unprocessable
orgs-20240630_def.xml	Edgar Link	unprocessable
orgs-20240630_lab.xml	Edgar Link	unprocessable
orgs-20240630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGS
Orgenesis Inc. Stock $orgs

2024 Q3 Form 10-Q Financial Statement

#000149315224030760 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS Orgenesis Inc. Stock $orgs

2024 Q3 Form 10-Q Financial Statement

#000149315224030760 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS
Orgenesis Inc. Stock $orgs